...
首页> 外文期刊>VASA: Zeitschrift fuer Gefarsskrankheiten. Journal for vascular diseases >Ablation therapy with cyanoacrylate glue and laser for refluxing great saphenous veins - a prospective randomised study
【24h】

Ablation therapy with cyanoacrylate glue and laser for refluxing great saphenous veins - a prospective randomised study

机译:用氰基丙烯酸盐胶水和激光回流伟大的隐静脉的消融治疗 - 一种预期随机研究

获取原文
获取原文并翻译 | 示例

摘要

Background: Endovenous cyanoacrylate ablation is a new technique for the treatment of clinically symptomatic venous insufficiency. The results of a prospective comparative study of cyaroacrylate glue versus endovenous laser ablation for the management of incompetent great sapherous veins are presented. Patients and methods: A total of 400 subjects were treated with cyanoacrylate ablation or endovenous laser ablation between April 2014 and April 2016. The preprocedural, procedural, postprocedural, and follow up data were recorded and compared. Results: There were 208 procedures in cyanoacrylate ablation group (CM) and 204 in endovenous laser ablation group (EVLA). Operative time was 13 +/- 3.4 minutes in the CAA and 31.7 +/- 8.8 minutes in the EVLA 0.001). All procedures in both groups were successful, and the target vein segments were fully occluded at the end e the procedure. Periprocedural pair was less in the CAA (< 0.001). Enduration, ecchymosis, and paresthesia rates were significantly higher it the EVLA (< 0.001). The mean length of follow-up was 14 months (range 10-16). The 3, 6 and 12 months closure rates were 97.4%, 95.6%, and 94.1% for EVLA and 98.6%, 97.1% and 96.6% for CAA respectively. In both groups, the Venous Clinical Severity Score and Chronic Venous Insufficiency Quality of Life Questionnaire with declined significantly with no difference between groups. Conclusions: Management of incompetent great saphenous veins both endovenous cyanoacrylate ablation and laser ablation results in high occlusion rates. Endovenous cyanoacrylate ablation technique is fast and simple with low periprocedural pain that does not require tumescent anesthesia and compression stockings.
机译:背景:统治氰基丙烯酸酯消融是一种治疗临床症状静脉功能不全的新技术。提出了一种前瞻性比较研究的胎酰胺胶与胚胎激光烧蚀对无能的大孢子静脉管理的结果。患者和方法:在2014年4月和2016年4月之间将共有400名受试者用氰基丙烯酸酯烧蚀或忠实激光烧蚀处理。记录并比较预先进行,程序,后期和后续数据。结果:氰基丙烯酸氰酸酯消融组(CM)和404中有208种方法(EVLA)。在CAA和31.7 +/- 8.8分钟内,操作时间为13 +/- 3.4分钟。两组中的所有程序都成功,目标静脉段在最终E的过程中完全封闭。 CAA中的Periprocedury对较少(<0.001)。 EVLA(<0.001)升高,EcChymosis和Parestesia率明显升高。随访的平均长度为14个月(范围10-16)。闭合率为97.4%,95.6%,94.1%,分别为98.6%,98.6%,97.1%和96.6%。在这两个群体中,静脉临床严重程度得分和慢性静脉功能不全的生命质量调查问卷随着群体之间没有差异而下降。结论:对无能的巨大隐甲酸静脉的管理既具有高闭塞率的根本氰基丙烯酸盐的静脉均匀。 Edencous氰基丙烯酸酯烧蚀技术快速简单,具有低纵横化疼痛,不需要肿胀麻醉和压缩丝袜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号